Assessing Polysaccharides/Aloe Vera-Based Hydrogels for Tumor Spheroid Formation.
aloe vera gel
hydrogel
natural polymer
polysaccharides
tumor spheroids
Journal
Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925
Informations de publication
Date de publication:
07 Jan 2023
07 Jan 2023
Historique:
received:
10
12
2022
revised:
03
01
2023
accepted:
05
01
2023
entrez:
20
1
2023
pubmed:
21
1
2023
medline:
21
1
2023
Statut:
epublish
Résumé
In vitro tumor spheroids have proven to be useful 3D tumor culture models for drug testing, and determining the molecular mechanism of tumor progression and cellular interactions. Therefore, there is a continuous search for their industrial scalability and routine preparation. Considering that hydrogels are promising systems that can favor the formation of tumor spheroids, our study aimed to investigate and develop less expensive and easy-to-use amorphous and crosslinked hydrogels, based on natural compounds such as sodium alginate (NaAlg), aloe vera (AV) gel powder, and chitosan (CS) for tumor spheroid formation. The ability of the developed hydrogels to be a potential spheroid-forming system was evaluated using MDA-MB-231 and U87MG cancer cells. Spheroid abilities were influenced by pH, viscosity, and crosslinking of the hydrogel. Addition of either AV or chitosan to sodium alginate increased the viscosity at pH 5, resulting in amorphous hydrogels with a strong gel texture, as shown by rheologic analysis. Only the chitosan-based gel allowed formation of spheroids at pH 5. Among the variants of AV-based amorphous hydrogels tested, only hydrogels at pH 12 and with low viscosity promoted the formation of spheroids. The crosslinked NaAlg/AV, NaAlg/AV/glucose, and NaAlg/CS hydrogel variants favored more efficient spheroid formation. Additional studies would be needed to use AV in other physical forms and other formulations of hydrogels, as the current study is an initiation, in evaluating the potential use of AV gel in tumor spheroid formation systems.
Identifiants
pubmed: 36661817
pii: gels9010051
doi: 10.3390/gels9010051
pmc: PMC9858450
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Agency for Higher Education, Research, Development and Innovation (UEFISCDI).
ID : PN-III-P2-2.1-PED-2021-3112 project (Grant No. 597PED ⁄ 2022)
Références
Int J Mol Sci. 2020 Mar 10;21(5):
pubmed: 32164316
Gels. 2022 Sep 21;8(10):
pubmed: 36286105
J Biomed Mater Res A. 2021 Oct;109(10):1990-2000
pubmed: 33811775
Biosensors (Basel). 2021 Nov 11;11(11):
pubmed: 34821661
Int J Biol Macromol. 2007 Feb 20;40(3):175-81
pubmed: 16893564
Macromol Biosci. 2020 Aug;20(8):e2000180
pubmed: 32794360
Soft Matter. 2019 Oct 9;15(39):7852-7862
pubmed: 31531488
Colloids Surf B Biointerfaces. 2016 Mar 1;139:211-8
pubmed: 26717508
PLoS One. 2015 Jun 19;10(6):e0130348
pubmed: 26090664
Molecules. 2020 Mar 13;25(6):
pubmed: 32183224
Polymers (Basel). 2022 Jun 30;14(13):
pubmed: 35808742
Carbohydr Polym. 2021 Nov 15;274:118633
pubmed: 34702456
Sci Rep. 2017 Jul 4;7(1):4575
pubmed: 28676662
Cancer Cell Int. 2017 May 16;17:55
pubmed: 28515673
Biomaterials. 2010 Aug;31(22):5903-10
pubmed: 20417555
J Agric Food Chem. 2021 Sep 15;69(36):10581-10591
pubmed: 34432461
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):399-404
pubmed: 19126683
Analyst. 2011 Feb 7;136(3):473-8
pubmed: 20967331
Adv Healthc Mater. 2018 Aug;7(15):e1800295
pubmed: 29893067
Nutrition. 2014 Feb;30(2):218-27
pubmed: 24262514
Polymers (Basel). 2022 Jan 17;14(2):
pubmed: 35054760
Biomimetics (Basel). 2021 Dec 28;7(1):
pubmed: 35076454
Theranostics. 2015 Mar 01;5(6):643-55
pubmed: 25825603
Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110932
pubmed: 32409080
ACS Appl Mater Interfaces. 2017 Jul 19;9(28):23520-23527
pubmed: 28661650
Carbohydr Polym. 2020 Oct 15;246:116571
pubmed: 32747243
Ann Biomed Eng. 2017 Apr;45(4):1003-1014
pubmed: 27904998
Sci Rep. 2015 Aug 07;5:13079
pubmed: 26248878
J Food Drug Anal. 2016 Jul;24(3):620-626
pubmed: 28911569
Cancer Converg. 2020;4(1):1
pubmed: 32090168
Phys Chem Chem Phys. 2015 Oct 28;17(40):26833-53
pubmed: 26400096
Polymers (Basel). 2019 Feb 03;11(2):
pubmed: 30960242
Biomaterials. 2014 Nov;35(33):9137-43
pubmed: 25109438
Molecules. 2008 Aug 08;13(8):1599-616
pubmed: 18794775
Biomaterials. 2010 Nov;31(32):8436-44
pubmed: 20692698
Trends Biotechnol. 2013 Feb;31(2):108-15
pubmed: 23336996
Mar Drugs. 2015 Mar 02;13(3):1133-74
pubmed: 25738328
Biotechnol Bioeng. 2003 Jul 20;83(2):173-80
pubmed: 12768623
Biomacromolecules. 2007 Aug;8(8):2533-41
pubmed: 17591747
Adv Healthc Mater. 2016 Dec;5(24):3173-3181
pubmed: 27805789
Sci Adv. 2018 Apr 27;4(4):eaas8998
pubmed: 29719868
Nat Mater. 2014 Oct;13(10):970-8
pubmed: 24930031
Cancers (Basel). 2020 Sep 23;12(10):
pubmed: 32977530
Materials (Basel). 2022 Jan 19;15(3):
pubmed: 35160695
ACS Appl Mater Interfaces. 2020 May 6;12(18):20912-20921
pubmed: 32255604
Adv Healthc Mater. 2018 Oct;7(20):e1800525
pubmed: 30073803
Biology (Basel). 2014 May 30;3(2):345-67
pubmed: 24887773
Adv Biosyst. 2020 Aug;4(8):e1900250
pubmed: 32686345
Biofabrication. 2021 Mar 10;13(2):
pubmed: 33440351
Cancers (Basel). 2022 Nov 05;14(21):
pubmed: 36358868
Brain Sci. 2021 Jul 31;11(8):
pubmed: 34439644
J Cell Physiol. 2019 Nov;234(11):20085-20097
pubmed: 30945284
Biotechnology (N Y). 1994 Jul;12(7):689-93
pubmed: 7764913
Biomaterials. 2010 Nov;31(32):8494-506
pubmed: 20709389